Diagnostic Breakthroughs for Neurodegenerative Diseases

R&D on Overdrive to Address Intensifying Disease Burden, Neuroimaging Technologies to Remain Gold-standard for Neurodiagnostic Applications

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic markets. The research service also includes drivers & challenges, market adoption, collaborations, funding and patent scenarios for neurodiagnostic technologies.

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology1.2 Research Methodology (continued)1.3 Key Findings2.0 R&D Portfolio Analysis2.1 Overview of Neurodegenerative Diseases2.2 Neurodegenerative Disease Diagnostics – Segmentation2.3 Biomarker-based Diagnostics: Overview2.3.1 Key Biomarkers for Neurodiagnostics2.3.2 Emerging Biomarker Diagnostics for MCI, AD, TBI, PD and Dementia2.3.3 Emerging Biomarker Diagnostics for ALS, FTD, TBI and AD2.4 Neuroimaging Technologies: Overview2.4.1 Neuroimaging Technologies 2.4.2 Neuroimaging Technologies2.4.3 Neuroimaging Technologies 2.4.4 Neuroimaging Technologies: Innovation Ecosystems2.5 Neuroinformatics: Overview2.6 Neuroinformatics: Innovation Ecosystems3.0 Funding Analysis3.1 Venture Investment Scenario for Neurobiomarkers3.2 Public Funding Landscape for Neurobiomarker Projects3.3 Summary of Key Public Funding Trends for Neurobiomarker Projects4.0 Environmental Analysis4.1 Key Technological Drivers and Challenges Across Neurodiagnostic Markets 4.1.1 Key Technologies Driving the Growth of Global Neurodiagnostic Markets4.1.2 Technological Challenges Across the Neurodiagnostic Sector4.2 Overview of Key Market Drivers and Challenges Across the Neurodiagnostic Sector 4.2.1 Key Market Drivers Fueling the Growth of the Global Neurodiagnostic Sector4.2.2 Key Market Challenges Impeding the Advancements of Neurodiagnostics4.3 Clinical Trials Analysis for Neuroimaging Markets in the US4.4 Adoption Scenario for Biomarker Diagnostics4.5 Adoption Scenario for Neuroimaging Techniques4.6 Adoption Scenario for Neuroinformatic Tools5.0 Strategic Insights5.1 Overview of the Collaborative Landscape Across Neurodiagnostic Markets5.2 Product Development Partnerships – Diagnostics5.3 Product Development Partnerships – Companion Diagnostics5.4 Licensing and Research Collaborations – Neurodiagnostics5.5 Research Consortia Across Global Neurodiagnostic Markets5.6 Emerging Technologies in Neurodiagnostics5.7 Conclusions6.0 Patent Analysis6.1 Patent Search Scope6.2 Patents for Neurodegenerative Diseases – Timeline Overview6.3 Global Patent Spread by Assignees6.4 Global Patent Spread by Patent Offices7.0 Key Contacts and Appendix7.1 Key Contacts7.2 Appendix I 7.2 Appendix I 7.3 Appendix II Legal Disclaimer8.0 The Frost & Sullivan Story8.1 The Frost & Sullivan Story8.2 Value Proposition: Future of Your Company & Career8.3 Global Perspective8.4 Industry Convergence8.5 360º Research Perspective8.6 Implementation Excellence8.7 Our Blue Ocean Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.